DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹358 Cr |
Mar2023 | ₹239 Cr |
Mar2022 | ₹345 Cr |
Mar2021 | ₹292 Cr |
Mar2020 | ₹226 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹358 Cr | 49.78 | |
Mar2023 | ₹239 Cr | -30.74 | |
Mar2022 | ₹345 Cr | 18.25 | |
Mar2021 | ₹292 Cr | 29.07 | |
Mar2020 | ₹226 Cr | - |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹21,955.0 Cr | -3.2% | -6.9% | 7.7% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹98,706.4 Cr | -0.5% | -4.7% | 16.3% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹90,561.3 Cr | -0.3% | -7.1% | -5.4% | Stock Analytics | |
FORTIS HEALTHCARE | ₹46,275.2 Cr | -0.4% | -6.2% | 39.4% | Stock Analytics | |
GLOBAL HEALTH | ₹30,357.1 Cr | 1.3% | 12.9% | -20.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹27,110.5 Cr | -2.2% | -0.1% | -1.8% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | -3.2% |
-6.9% |
7.7% |
SENSEX | -1.7% |
-0.8% |
5.8% |
You may also like the below Video Courses